Fundraising Fox

ReViral

5 known investors

Reviral operates an affiliate review site that ranks and reviews online casinos not registered with the UK's GamStop self-exclusion scheme, comparing licences, bonuses, wagering terms, payout speeds, and payment methods. It targets UK gambling players seeking offshore casino options licensed in jurisdictions such as Curaçao and Anjouan.

ConsumerMedia & Entertainment

Investors · 5

Andera PartnersParis
Brace PharmaAtlanta
New Leaf Venture PartnersreportedNew York
OrbiMedreportedNew York · $1M – $75M
Wellcome TrustreportedLondon

In the news

ReViral raises $44 million as it grows headquarters in Research Triangle Park - Triangle Business Journalbizjournals.com · Aug 2020ReViral Raises $44M in Series C Financing - FinSMEsfinsmes.com · Aug 2020ReViral Raises €47M to Develop First Treatment Against RSV Viruslabiotech.eu · Aug 2018ReViral raises $55M to run midphase RSV clinical trials | Fierce Biotechfiercebiotech.com · Aug 2018Reviral Announces Us$21 Million Fundraising To Advance Clinical Development Of A Novel Anti-Viral Drug - BioSpacebiospace.com · Sep 2015ReViral raises US$55m - European Biotechnologyeuropean-biotechnology.com

Frequently asked questions

What does ReViral do?
Reviral operates an affiliate review site that ranks and reviews online casinos not registered with the UK's GamStop self-exclusion scheme, comparing licences, bonuses, wagering terms, payout speeds, and payment methods. It targets UK gambling players seeking offshore casino options licensed in jurisdictions such as Curaçao and Anjouan.
Who are ReViral's investors?
ReViral's investors include Andera Partners, Brace Pharma, New Leaf Venture Partners, OrbiMed, Wellcome Trust.